NEW YORK, May 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
http://www.reportlinker.com/p0511072/Drug-Delivery-Devices-Market-Outlook-in-China-to-2017---Metered-Dose-Inhaler-Devices-Infusion-Systems-Central-Venous-Catheters-and-Needle-Free-Injections.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Summary
GlobalData's new report, "Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections" provides key market data on the China Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market categories.
- Global corporate-level profiles of key companies operating within the China Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Sunovion, Fresenius Kabi AG, 3M Health Care and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the China Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What is This Report About? 11
3 Drug Delivery Devices In China 12
3.1 Drug Delivery Devices, Market Segmentation 12
3.2 Drug Delivery Devices, China, Overall Revenue ($m), 2003-2017 13
3.3 Drug Delivery Devices Market, China, Revenue Mix ($m), 2010 15
3.4 Drug Delivery Devices Market, China, Category Contribution (%), 2010 16
3.5 Drug Delivery Devices, China, Category Volume (Units), 2003-2017 22
3.6 Drug Delivery Devices, China, Company Share (2009-2010) 27
4 Central Venous Catheters In China 29
4.1 Central Venous Catheters, Market Segmentation 29
4.2 Central Venous Catheters Market, China, Revenue Mix ($m), 2010 30
4.3 Central Venous Catheters Market, China, Segment Contribution (%), 2010 31
4.4 Central Venous Catheters Overall Revenue (2003-2017) 32
4.5 Central Venous Catheters Overall Volume (2003-2017) 36
4.6 Central Venous Catheters Average Price (2003-2017) 39
4.7 Central Venous Catheters Distribution Share (2009-2010) 40
4.8 Central Venous Catheters, China, Company Share (2009-2010) 41
5 Infusion Systems In China 43
5.1 Infusion Systems, Market Segmentation 43
5.2 Infusion Systems Market, China, Revenue Mix ($m), 2010 44
5.3 Infusion Systems Market, China, Segment Contribution (%), 2010 45
5.4 Infusion Systems Overall Revenue (2003-2017) 46
5.4.1 Syringe Pumps Revenue (2003-2017) 50
5.4.2 Ambulatory Infusion Pumps Revenue (2003-2017) 54
5.5 Infusion Systems Overall Volume (2003-2017) 58
5.5.1 Syringe Pumps Volume (2003-2017) 62
5.5.2 Ambulatory Infusion Pumps Volume (2003-2017) 65
5.6 Infusion Systems Average Price (2003-2017) 69
5.7 Infusion Systems Distribution Share (2009-2010) 70
5.8 Infusion Systems, China, Company Share (2009-2010) 71
6 Metered Dose Inhaler Devices In China 73
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 73
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 75
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 77
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 78
6.5 Metered Dose Inhaler Devices, China, Company Share (2009-2010) 79
7 Needle Free Injections In China 81
7.1 Needle Free Injections Overall Revenue (2003-2017) 81
7.2 Needle Free Injections Overall Volume (2003-2017) 83
7.3 Needle Free Injections Average Price (2003-2017) 85
7.4 Needle Free Injections Distribution Share (2009-2010) 86
7.5 Needle Free Injections, China, Company Share (2009-2010) 87
8 Overview of Key Companies in China Drug Delivery Devices Market 88
8.1 GlaxoSmithKline plc 88
8.1.1 Company Overview 88
8.1.2 Share in the China Drug Delivery Devices Market 88
8.2 AstraZeneca PLC 89
8.2.1 Company Overview 89
8.2.2 Share in the China Drug Delivery Devices Market 89
8.3 Boehringer Ingelheim GmbH 90
8.3.1 Company Overview 90
8.3.2 Share in the China Drug Delivery Devices Market 90
8.4 Sunovion 91
8.4.1 Share in the China Drug Delivery Devices Market 91
8.5 Fresenius Kabi AG 92
8.5.1 Company Overview 92
8.5.2 Share in the China Drug Delivery Devices Market 92
8.6 3M Health Care 93
8.6.1 Company Overview 93
8.7 Baxter International Inc. 93
8.7.1 Company Overview 93
8.8 Terumo Corporation 93
8.8.1 Company Overview 93
8.9 Teleflex Incorporated 94
8.9.1 Company Overview 94
8.10 Hospira, Inc. 94
8.10.1 Company Overview 94
8.11 Medtronic, Inc. 95
8.11.1 Company Overview 95
8.12 Consort Medical plc 95
8.12.1 Company Overview 95
8.13 Smiths Medical 95
8.13.1 Company Overview 95
8.14 JMS CO., LTD. 96
8.14.1 Company Overview 96
8.15 CareFusion Corporation 96
8.15.1 Company Overview 96
8.16 NIPRO CORPORATION 97
8.16.1 Company Overview 97
8.17 B. Braun Melsungen AG 97
8.17.1 Company Overview 97
8.18 Edwards Lifesciences Corporation 97
8.18.1 Company Overview 97
8.19 INJEX - Equidyne Systems 98
8.19.1 Company Overview 98
8.20 Bioject Medical Technologies Inc. 98
8.20.1 Company Overview 98
9 Drug Delivery Devices Market Pipeline Products 99
10 Financial Deals Landscape 104
10.1 Acquisition 104
10.1.1 Mindray Medical International to Acquire Controlling Stake in Shenzhen Shenke Medical Instrument 104
10.2 Partnerships 105
10.2.1 Bayer Schering Pharma Enters Into An Agreement With National Pharmaceutical Engineering Research Center 105
11 Appendix 106
11.1 Definitions of Markets Covered in the Report 107
11.1.1 Drug Delivery Devices 107
11.2 Research Methodology 110
11.3 Secondary Research 110
11.4 Primary Research 111
11.5 Models 111
11.6 Forecasts 112
11.7 Expert Panels 112
11.8 GlobalData Consulting 112
11.9 Currency Conversion 112
11.10 Contact Us 113
11.11 Disclaimer 113
1.1 List of Tables
Table 1: Drug Delivery Devices, China, Overall Revenue ($m), 2003-2017 14
Table 2: Drug Delivery Devices Market, China, Category Contribution (%), 2010 16
Table 3: Drug Delivery Devices, China Cross-Category Analysis, 2003-2017 17
Table 4: Drug Delivery Devices, China, Overall Revenue ($m), Historic, 2003-2010 19
Table 5: Drug Delivery Devices, China, Overall Revenue ($m), Forecast, 2010-2017 21
Table 6: Drug Delivery Devices, China, Category Volume (Units), 2003-2017 22
Table 7: Drug Delivery Devices, China, Category Volume (Units), Historic, 2003-2010 24
Table 8: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2010-2017 26
Table 9: Drug Delivery Devices, China, Company Share by Revenue ($m), 2009-2010 28
Table 10: Central Venous Catheters Market, China, Segment Contribution (%), 2010 31
Table 11: Central Venous Catheters, China, Revenue ($m) by Segment, Historic, 2003-2010 33
Table 12: Central Venous Catheters, China, Revenue ($m) by Segment, Forecast, 2010-2017 35
Table 13: Central Venous Catheters, China, Volume (Units) by Segment, Historic, 2003-2010 37
Table 14: Central Venous Catheters, China, Volume (Units) by Segment, Forecast, 2010-2017 38
Table 15: Central Venous Catheters, China, Average Price ($), Historic, 2003-2010 39
Table 16: Central Venous Catheters, China, Average Price ($), Forecast, 2010-2017 39
Table 17: Central Venous Catheters, China, Distribution Share by Revenue ($m), 2009-2010 40
Table 18: Central Venous Catheters, China, Company Share by Revenue ($m), 2009-2010 42
Table 19: Infusion Systems Market, China, Segment Contribution (%), 2010 45
Table 20: Infusion Systems, China, Revenue ($m) by Segment, Historic, 2003-2010 47
Table 21: Infusion Systems, China, Revenue ($m) by Segment, Forecast, 2010-2017 49
Table 22: Syringe Pumps, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 51
Table 23: Syringe Pumps, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 53
Table 24: Ambulatory Infusion Pumps, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 55
Table 25: Ambulatory Infusion Pumps, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 57
Table 26: Infusion Systems, China, Volume (Units) by Segment, Historic, 2003-2010 59
Table 27: Infusion Systems, China, Volume (Units) by Segment, Forecast, 2010-2017 61
Table 28: Syringe Pumps, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 63
Table 29: Syringe Pumps, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 64
Table 30: Ambulatory Infusion Pumps, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 66
Table 31: Ambulatory Infusion Pumps, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68
Table 32: Infusion Systems, China, Average Price ($), Historic, 2003-2010 69
Table 33: Infusion Systems, China, Average Price ($), Forecast, 2010-2017 69
Table 34: Infusion Systems, China, Distribution Share by Revenue ($m), 2009-2010 70
Table 35: Infusion Systems, China, Company Share by Revenue ($m), 2009-2010 72
Table 36: Metered Dose Inhaler Devices, China, Revenue ($m), Historic, 2003-2010 73
Table 37: Metered Dose Inhaler Devices, China, Revenue ($m), Forecast, 2010-2017 74
Table 38: Metered Dose Inhaler Devices, China, Volume (Units), Historic, 2003-2010 75
Table 39: Metered Dose Inhaler Devices, China, Volume (Units), Forecast, 2010-2017 76
Table 40: Metered Dose Inhaler Devices, China, Average Price ($), Historic, 2003-2010 77
Table 41: Metered Dose Inhaler Devices, China, Average Price ($), Forecast, 2010-2017 77
Table 42: Metered Dose Inhaler Devices, China, Distribution Share by Revenue ($m), 2009-2010 78
Table 43: Metered Dose Inhaler Devices, China, Company Share by Revenue ($m), 2009-2010 80
Table 44: Needle Free Injections, China, Revenue ($m), Historic, 2003-2010 81
Table 45: Needle Free Injections, China, Revenue ($m), Forecast, 2010-2017 82
Table 46: Needle Free Injections, China, Volume (Units), Historic, 2003-2010 83
Table 47: Needle Free Injections, China, Volume (Units), Forecast, 2010-2017 84
Table 48: Needle Free Injections, China, Average Price ($), Historic, 2003-2010 85
Table 49: Needle Free Injections, China, Average Price ($), Forecast, 2010-2017 85
Table 50: Needle Free Injections, China, Distribution Share by Revenue ($m), 2009-2010 86
Table 51: Needle Free Injections, China, Company Share by Revenue ($m), 2009-2010 87
Table 52: Drug Delivery Devices Market Pipeline Products 99
Table 53: Mindray Medical International To Acquire Controlling Stake In Shenzhen Shenke Medical Instrument 104
Table 54: Bayer Schering Pharma Enters Into An Agreement With National Pharmaceutical Engineering Research Center 105
Table 55: USD to Local Currency, China, Average Actual Rate 2003-2010 112
1.2 List of Figures
Figure 1: Drug Delivery Devices, Market Segmentation 12
Figure 2: Drug Delivery Devices, China, Overall Revenue ($m), 2003-2017 13
Figure 3: Drug Delivery Devices Market, China, Revenue Mix ($m), 2010 15
Figure 4: Drug Delivery Devices Market, China, Category Contribution (%), 2010 16
Figure 5: Drug Delivery Devices, China, Cross-Category Analysis, 2003-2017 17
Figure 6: Drug Delivery Devices, China, Overall Revenue ($m), Historic, 2003-2010 18
Figure 7: Drug Delivery Devices, China, Overall Revenue ($m), Forecast, 2010-2017 20
Figure 8: Drug Delivery Devices, China, Category Volume (Units), 2003-2017 22
Figure 9: Drug Delivery Devices, China, Category Volume (Units), Historic, 2003-2010 23
Figure 10: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2010-2017 25
Figure 11: Drug Delivery Devices, China, Company Share (%), 2010 27
Figure 12: Central Venous Catheters, Market Segmentation 29
Figure 13: Central Venous Catheters Market, China, Revenue Mix ($m), 2010 30
Figure 14: Central Venous Catheters Market, China, Segment Contribution (%), 2010 31
Figure 15: Central Venous Catheters, China, Revenue ($m) by Segment, Historic, 2003-2010 32
Figure 16: Central Venous Catheters, China, Revenue ($m) by Segment, Forecast, 2010-2017 34
Figure 17: Central Venous Catheters, China, Volume (Units) by Segment, Historic, 2003-2010 36
Figure 18: Central Venous Catheters, China, Volume (Units) by Segment, Forecast, 2010-2017 38
Figure 19: Central Venous Catheters, China, Company Share (%), 2010 41
Figure 20: Infusion Systems, Market Segmentation 43
Figure 21: Infusion Systems Market, China, Revenue Mix ($m), 2010 44
Figure 22: Infusion Systems Market, China, Segment Contribution (%), 2010 45
Figure 23: Infusion Systems, China, Revenue ($m) by Segment, Historic, 2003-2010 46
Figure 24: Infusion Systems, China, Revenue ($m) by Segment, Forecast, 2010-2017 48
Figure 25: Syringe Pumps, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 50
Figure 26: Syringe Pumps, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 52
Figure 27: Ambulatory Infusion Pumps, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 54
Figure 28: Ambulatory Infusion Pumps, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 56
Figure 29: Infusion Systems, China, Volume (Units) by Segment, Historic, 2003-2010 58
Figure 30: Infusion Systems, China, Volume (Units) by Segment, Forecast, 2010-2017 60
Figure 31: Syringe Pumps, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 62
Figure 32: Syringe Pumps, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 64
Figure 33: Ambulatory Infusion Pumps, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 65
Figure 34: Ambulatory Infusion Pumps, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 67
Figure 35: Infusion Systems, China, Company Share (%), 2010 71
Figure 36: Metered Dose Inhaler Devices, China, Revenue ($m), Historic, 2003-2010 73
Figure 37: Metered Dose Inhaler Devices, China, Revenue ($m), Forecast, 2010-2017 74
Figure 38: Metered Dose Inhaler Devices, China, Volume (Units), Historic, 2003-2010 75
Figure 39: Metered Dose Inhaler Devices, China, Volume (Units), Forecast, 2010-2017 76
Figure 40: Metered Dose Inhaler Devices, China, Company Share (%), 2010 79
Figure 41: Needle Free Injections, China, Revenue ($m), Historic, 2003-2010 81
Figure 42: Needle Free Injections, China, Revenue ($m), Forecast, 2010-2017 82
Figure 43: Needle Free Injections, China, Volume (Units), Historic, 2003-2010 83
Figure 44: Needle Free Injections, China, Volume (Units), Forecast, 2010-2017 84
Figure 45: Needle Free Injections, China, Company Share (%), 2010 87
Figure 46: GlaxoSmithKline plc, Company Share (%),China Drug Delivery Devices Market, 2010 88
Figure 47: AstraZeneca PLC, Company Share (%),China Drug Delivery Devices Market, 2010 89
Figure 48: Boehringer Ingelheim GmbH, Company Share (%),China Drug Delivery Devices Market, 2010 90
Figure 49: Sunovion, Company Share (%),China Drug Delivery Devices Market, 2010 91
Figure 50: Fresenius Kabi AG, Company Share (%),China Drug Delivery Devices Market, 2010 92
Companies Mentioned
GlaxoSmithKline plc
AstraZeneca PLC
Boehringer Ingelheim GmbH
Sunovion
Fresenius Kabi AG
3M Health Care
Baxter International Inc.
Terumo Corporation
Teleflex Incorporated
Hospira, Inc.
Medtronic, Inc.
Consort Medical plc
Smiths Medical
JMS CO., LTD.
CareFusion Corporation
NIPRO CORPORATION
B. Braun Melsungen AG
Edwards Lifesciences Corporation
INJEX - Equidyne Systems
Bioject Medical Technologies Inc.
To order this report:
Drug Delivery Technology Industry: Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Drug Delivery Technology Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT: Nicolas BombourgReportlinkerEmail: [email protected]US: +1-805-652-2626Intl: +1-805-652-2626
SOURCE Reportlinker
Advertisement
Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Advertisement
http://www.reportlinker.com/p0511072/Drug-Delivery-Devices-Market-Outlook-in-China-to-2017---Metered-Dose-Inhaler-Devices-Infusion-Systems-Central-Venous-Catheters-and-Needle-Free-Injections.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Summary
GlobalData's new report, "Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections" provides key market data on the China Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market categories.
- Global corporate-level profiles of key companies operating within the China Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Sunovion, Fresenius Kabi AG, 3M Health Care and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the China Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What is This Report About? 11
3 Drug Delivery Devices In China 12
3.1 Drug Delivery Devices, Market Segmentation 12
3.2 Drug Delivery Devices, China, Overall Revenue ($m), 2003-2017 13
3.3 Drug Delivery Devices Market, China, Revenue Mix ($m), 2010 15
3.4 Drug Delivery Devices Market, China, Category Contribution (%), 2010 16
3.5 Drug Delivery Devices, China, Category Volume (Units), 2003-2017 22
3.6 Drug Delivery Devices, China, Company Share (2009-2010) 27
4 Central Venous Catheters In China 29
4.1 Central Venous Catheters, Market Segmentation 29
4.2 Central Venous Catheters Market, China, Revenue Mix ($m), 2010 30
4.3 Central Venous Catheters Market, China, Segment Contribution (%), 2010 31
4.4 Central Venous Catheters Overall Revenue (2003-2017) 32
4.5 Central Venous Catheters Overall Volume (2003-2017) 36
4.6 Central Venous Catheters Average Price (2003-2017) 39
4.7 Central Venous Catheters Distribution Share (2009-2010) 40
4.8 Central Venous Catheters, China, Company Share (2009-2010) 41
5 Infusion Systems In China 43
5.1 Infusion Systems, Market Segmentation 43
5.2 Infusion Systems Market, China, Revenue Mix ($m), 2010 44
5.3 Infusion Systems Market, China, Segment Contribution (%), 2010 45
5.4 Infusion Systems Overall Revenue (2003-2017) 46
5.4.1 Syringe Pumps Revenue (2003-2017) 50
5.4.2 Ambulatory Infusion Pumps Revenue (2003-2017) 54
5.5 Infusion Systems Overall Volume (2003-2017) 58
5.5.1 Syringe Pumps Volume (2003-2017) 62
5.5.2 Ambulatory Infusion Pumps Volume (2003-2017) 65
5.6 Infusion Systems Average Price (2003-2017) 69
5.7 Infusion Systems Distribution Share (2009-2010) 70
5.8 Infusion Systems, China, Company Share (2009-2010) 71
6 Metered Dose Inhaler Devices In China 73
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 73
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 75
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 77
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 78
6.5 Metered Dose Inhaler Devices, China, Company Share (2009-2010) 79
7 Needle Free Injections In China 81
7.1 Needle Free Injections Overall Revenue (2003-2017) 81
7.2 Needle Free Injections Overall Volume (2003-2017) 83
7.3 Needle Free Injections Average Price (2003-2017) 85
7.4 Needle Free Injections Distribution Share (2009-2010) 86
7.5 Needle Free Injections, China, Company Share (2009-2010) 87
8 Overview of Key Companies in China Drug Delivery Devices Market 88
8.1 GlaxoSmithKline plc 88
8.1.1 Company Overview 88
8.1.2 Share in the China Drug Delivery Devices Market 88
8.2 AstraZeneca PLC 89
8.2.1 Company Overview 89
8.2.2 Share in the China Drug Delivery Devices Market 89
8.3 Boehringer Ingelheim GmbH 90
8.3.1 Company Overview 90
8.3.2 Share in the China Drug Delivery Devices Market 90
8.4 Sunovion 91
8.4.1 Share in the China Drug Delivery Devices Market 91
8.5 Fresenius Kabi AG 92
8.5.1 Company Overview 92
8.5.2 Share in the China Drug Delivery Devices Market 92
8.6 3M Health Care 93
8.6.1 Company Overview 93
8.7 Baxter International Inc. 93
8.7.1 Company Overview 93
8.8 Terumo Corporation 93
8.8.1 Company Overview 93
8.9 Teleflex Incorporated 94
8.9.1 Company Overview 94
8.10 Hospira, Inc. 94
8.10.1 Company Overview 94
8.11 Medtronic, Inc. 95
8.11.1 Company Overview 95
8.12 Consort Medical plc 95
8.12.1 Company Overview 95
8.13 Smiths Medical 95
8.13.1 Company Overview 95
8.14 JMS CO., LTD. 96
8.14.1 Company Overview 96
8.15 CareFusion Corporation 96
8.15.1 Company Overview 96
8.16 NIPRO CORPORATION 97
8.16.1 Company Overview 97
8.17 B. Braun Melsungen AG 97
8.17.1 Company Overview 97
8.18 Edwards Lifesciences Corporation 97
8.18.1 Company Overview 97
8.19 INJEX - Equidyne Systems 98
8.19.1 Company Overview 98
8.20 Bioject Medical Technologies Inc. 98
8.20.1 Company Overview 98
9 Drug Delivery Devices Market Pipeline Products 99
10 Financial Deals Landscape 104
10.1 Acquisition 104
10.1.1 Mindray Medical International to Acquire Controlling Stake in Shenzhen Shenke Medical Instrument 104
10.2 Partnerships 105
10.2.1 Bayer Schering Pharma Enters Into An Agreement With National Pharmaceutical Engineering Research Center 105
11 Appendix 106
11.1 Definitions of Markets Covered in the Report 107
11.1.1 Drug Delivery Devices 107
11.2 Research Methodology 110
11.3 Secondary Research 110
11.4 Primary Research 111
11.5 Models 111
11.6 Forecasts 112
11.7 Expert Panels 112
11.8 GlobalData Consulting 112
11.9 Currency Conversion 112
11.10 Contact Us 113
11.11 Disclaimer 113
1.1 List of Tables
Table 1: Drug Delivery Devices, China, Overall Revenue ($m), 2003-2017 14
Table 2: Drug Delivery Devices Market, China, Category Contribution (%), 2010 16
Table 3: Drug Delivery Devices, China Cross-Category Analysis, 2003-2017 17
Table 4: Drug Delivery Devices, China, Overall Revenue ($m), Historic, 2003-2010 19
Table 5: Drug Delivery Devices, China, Overall Revenue ($m), Forecast, 2010-2017 21
Table 6: Drug Delivery Devices, China, Category Volume (Units), 2003-2017 22
Table 7: Drug Delivery Devices, China, Category Volume (Units), Historic, 2003-2010 24
Table 8: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2010-2017 26
Table 9: Drug Delivery Devices, China, Company Share by Revenue ($m), 2009-2010 28
Table 10: Central Venous Catheters Market, China, Segment Contribution (%), 2010 31
Table 11: Central Venous Catheters, China, Revenue ($m) by Segment, Historic, 2003-2010 33
Table 12: Central Venous Catheters, China, Revenue ($m) by Segment, Forecast, 2010-2017 35
Table 13: Central Venous Catheters, China, Volume (Units) by Segment, Historic, 2003-2010 37
Table 14: Central Venous Catheters, China, Volume (Units) by Segment, Forecast, 2010-2017 38
Table 15: Central Venous Catheters, China, Average Price ($), Historic, 2003-2010 39
Table 16: Central Venous Catheters, China, Average Price ($), Forecast, 2010-2017 39
Table 17: Central Venous Catheters, China, Distribution Share by Revenue ($m), 2009-2010 40
Table 18: Central Venous Catheters, China, Company Share by Revenue ($m), 2009-2010 42
Table 19: Infusion Systems Market, China, Segment Contribution (%), 2010 45
Table 20: Infusion Systems, China, Revenue ($m) by Segment, Historic, 2003-2010 47
Table 21: Infusion Systems, China, Revenue ($m) by Segment, Forecast, 2010-2017 49
Table 22: Syringe Pumps, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 51
Table 23: Syringe Pumps, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 53
Table 24: Ambulatory Infusion Pumps, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 55
Table 25: Ambulatory Infusion Pumps, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 57
Table 26: Infusion Systems, China, Volume (Units) by Segment, Historic, 2003-2010 59
Table 27: Infusion Systems, China, Volume (Units) by Segment, Forecast, 2010-2017 61
Table 28: Syringe Pumps, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 63
Table 29: Syringe Pumps, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 64
Table 30: Ambulatory Infusion Pumps, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 66
Table 31: Ambulatory Infusion Pumps, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 68
Table 32: Infusion Systems, China, Average Price ($), Historic, 2003-2010 69
Table 33: Infusion Systems, China, Average Price ($), Forecast, 2010-2017 69
Table 34: Infusion Systems, China, Distribution Share by Revenue ($m), 2009-2010 70
Table 35: Infusion Systems, China, Company Share by Revenue ($m), 2009-2010 72
Table 36: Metered Dose Inhaler Devices, China, Revenue ($m), Historic, 2003-2010 73
Table 37: Metered Dose Inhaler Devices, China, Revenue ($m), Forecast, 2010-2017 74
Table 38: Metered Dose Inhaler Devices, China, Volume (Units), Historic, 2003-2010 75
Table 39: Metered Dose Inhaler Devices, China, Volume (Units), Forecast, 2010-2017 76
Table 40: Metered Dose Inhaler Devices, China, Average Price ($), Historic, 2003-2010 77
Table 41: Metered Dose Inhaler Devices, China, Average Price ($), Forecast, 2010-2017 77
Table 42: Metered Dose Inhaler Devices, China, Distribution Share by Revenue ($m), 2009-2010 78
Table 43: Metered Dose Inhaler Devices, China, Company Share by Revenue ($m), 2009-2010 80
Table 44: Needle Free Injections, China, Revenue ($m), Historic, 2003-2010 81
Table 45: Needle Free Injections, China, Revenue ($m), Forecast, 2010-2017 82
Table 46: Needle Free Injections, China, Volume (Units), Historic, 2003-2010 83
Table 47: Needle Free Injections, China, Volume (Units), Forecast, 2010-2017 84
Table 48: Needle Free Injections, China, Average Price ($), Historic, 2003-2010 85
Table 49: Needle Free Injections, China, Average Price ($), Forecast, 2010-2017 85
Table 50: Needle Free Injections, China, Distribution Share by Revenue ($m), 2009-2010 86
Table 51: Needle Free Injections, China, Company Share by Revenue ($m), 2009-2010 87
Table 52: Drug Delivery Devices Market Pipeline Products 99
Table 53: Mindray Medical International To Acquire Controlling Stake In Shenzhen Shenke Medical Instrument 104
Table 54: Bayer Schering Pharma Enters Into An Agreement With National Pharmaceutical Engineering Research Center 105
Table 55: USD to Local Currency, China, Average Actual Rate 2003-2010 112
1.2 List of Figures
Figure 1: Drug Delivery Devices, Market Segmentation 12
Figure 2: Drug Delivery Devices, China, Overall Revenue ($m), 2003-2017 13
Figure 3: Drug Delivery Devices Market, China, Revenue Mix ($m), 2010 15
Figure 4: Drug Delivery Devices Market, China, Category Contribution (%), 2010 16
Figure 5: Drug Delivery Devices, China, Cross-Category Analysis, 2003-2017 17
Figure 6: Drug Delivery Devices, China, Overall Revenue ($m), Historic, 2003-2010 18
Figure 7: Drug Delivery Devices, China, Overall Revenue ($m), Forecast, 2010-2017 20
Figure 8: Drug Delivery Devices, China, Category Volume (Units), 2003-2017 22
Figure 9: Drug Delivery Devices, China, Category Volume (Units), Historic, 2003-2010 23
Figure 10: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2010-2017 25
Figure 11: Drug Delivery Devices, China, Company Share (%), 2010 27
Figure 12: Central Venous Catheters, Market Segmentation 29
Figure 13: Central Venous Catheters Market, China, Revenue Mix ($m), 2010 30
Figure 14: Central Venous Catheters Market, China, Segment Contribution (%), 2010 31
Figure 15: Central Venous Catheters, China, Revenue ($m) by Segment, Historic, 2003-2010 32
Figure 16: Central Venous Catheters, China, Revenue ($m) by Segment, Forecast, 2010-2017 34
Figure 17: Central Venous Catheters, China, Volume (Units) by Segment, Historic, 2003-2010 36
Figure 18: Central Venous Catheters, China, Volume (Units) by Segment, Forecast, 2010-2017 38
Figure 19: Central Venous Catheters, China, Company Share (%), 2010 41
Figure 20: Infusion Systems, Market Segmentation 43
Figure 21: Infusion Systems Market, China, Revenue Mix ($m), 2010 44
Figure 22: Infusion Systems Market, China, Segment Contribution (%), 2010 45
Figure 23: Infusion Systems, China, Revenue ($m) by Segment, Historic, 2003-2010 46
Figure 24: Infusion Systems, China, Revenue ($m) by Segment, Forecast, 2010-2017 48
Figure 25: Syringe Pumps, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 50
Figure 26: Syringe Pumps, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 52
Figure 27: Ambulatory Infusion Pumps, China, Revenue ($m) by Sub-Segment, Historic, 2003-2010 54
Figure 28: Ambulatory Infusion Pumps, China, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 56
Figure 29: Infusion Systems, China, Volume (Units) by Segment, Historic, 2003-2010 58
Figure 30: Infusion Systems, China, Volume (Units) by Segment, Forecast, 2010-2017 60
Figure 31: Syringe Pumps, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 62
Figure 32: Syringe Pumps, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 64
Figure 33: Ambulatory Infusion Pumps, China, Volume (Units) by Sub-Segment, Historic, 2003-2010 65
Figure 34: Ambulatory Infusion Pumps, China, Volume (Units) by Sub-Segment, Forecast, 2010-2017 67
Figure 35: Infusion Systems, China, Company Share (%), 2010 71
Figure 36: Metered Dose Inhaler Devices, China, Revenue ($m), Historic, 2003-2010 73
Figure 37: Metered Dose Inhaler Devices, China, Revenue ($m), Forecast, 2010-2017 74
Figure 38: Metered Dose Inhaler Devices, China, Volume (Units), Historic, 2003-2010 75
Figure 39: Metered Dose Inhaler Devices, China, Volume (Units), Forecast, 2010-2017 76
Figure 40: Metered Dose Inhaler Devices, China, Company Share (%), 2010 79
Figure 41: Needle Free Injections, China, Revenue ($m), Historic, 2003-2010 81
Figure 42: Needle Free Injections, China, Revenue ($m), Forecast, 2010-2017 82
Figure 43: Needle Free Injections, China, Volume (Units), Historic, 2003-2010 83
Figure 44: Needle Free Injections, China, Volume (Units), Forecast, 2010-2017 84
Figure 45: Needle Free Injections, China, Company Share (%), 2010 87
Figure 46: GlaxoSmithKline plc, Company Share (%),China Drug Delivery Devices Market, 2010 88
Figure 47: AstraZeneca PLC, Company Share (%),China Drug Delivery Devices Market, 2010 89
Figure 48: Boehringer Ingelheim GmbH, Company Share (%),China Drug Delivery Devices Market, 2010 90
Figure 49: Sunovion, Company Share (%),China Drug Delivery Devices Market, 2010 91
Figure 50: Fresenius Kabi AG, Company Share (%),China Drug Delivery Devices Market, 2010 92
Companies Mentioned
GlaxoSmithKline plc
AstraZeneca PLC
Boehringer Ingelheim GmbH
Sunovion
Fresenius Kabi AG
3M Health Care
Baxter International Inc.
Terumo Corporation
Teleflex Incorporated
Hospira, Inc.
Medtronic, Inc.
Consort Medical plc
Smiths Medical
JMS CO., LTD.
CareFusion Corporation
NIPRO CORPORATION
B. Braun Melsungen AG
Edwards Lifesciences Corporation
INJEX - Equidyne Systems
Bioject Medical Technologies Inc.
To order this report:
Drug Delivery Technology Industry: Drug Delivery Devices Market Outlook in China to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Drug Delivery Technology Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT: Nicolas BombourgReportlinkerEmail: [email protected]US: +1-805-652-2626Intl: +1-805-652-2626
SOURCE Reportlinker
